Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy.
about
Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathyGene therapy in animal models of rheumatoid arthritis: are we ready for the patients?NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destructionEffect of a small molecule inhibitor of nuclear factor-kappaB nuclear translocation in a murine model of arthritis and cultured human synovial cellsImportance of NF-kappaB in rheumatoid synovial tissues: in situ NF-kappaB expression and in vitro study using cultured synovial cellsNF-kappaB: a key role in inflammatory diseasesRheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis.Therapeutic applications of transcription factor decoy oligonucleotidesTreatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides.Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets.STAT proteins: novel molecular targets for cancer drug discovery.Inhibition of osteoclastogenesis by RNA interference targeting RANK.Matrix metalloproteinases as therapeutic targets in arthritic diseases: bull's-eye or missing the mark?Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus.THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritisIs NF-kappaB a useful therapeutic target in rheumatoid arthritis?Plant alkaloid tetrandrine downregulates IkappaBalpha kinases-IkappaBalpha-NF-kappaB signaling pathway in human peripheral blood T cell.Molecular aspects of glucocorticoid hormone action in rheumatoid arthritis.Regulation of B cell activating factor (BAFF) receptor expression by NF-ΚB signaling in rheumatoid arthritis B cellsRole of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents.Celiac disease: a model autoimmune disease with gene therapy applications.Gene therapy for arthritis.Perspectives on the use of gene therapy for chronic joint diseases.Gene transfer as a future therapy for rheumatoid arthritis.SPA0355, a thiourea analogue, inhibits inflammatory responses and joint destruction in fibroblast-like synoviocytes and mice with collagen-induced arthritis.Inhibitory effect of ribbon-type NF-kappaB decoy oligodeoxynucleotides on osteoclast induction and activity in vitro and in vivoThe role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy.Therapeutic potential of decoy oligonucleotides strategy in cardiovascular diseases.Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis.RNA therapeutics targeting osteoclast-mediated excessive bone resorption.Immunosuppressive exosomes: a new approach for treating arthritis.Cytokine signal regulation and autoimmune disorders.Liposomes in the treatment of inflammatory disorders.Cells of the synovium in rheumatoid arthritis. Dendritic cells.Regulation of NF-kappaB signaling by decoy oligodeoxynucleotides.NF-kappa B as a therapeutic target in autoimmune disease.Hyperoside exerts anti-inflammatory and anti-arthritic effects in LPS-stimulated human fibroblast-like synoviocytes in vitro and in mice with collagen-induced arthritis.Arthritis severity locus Cia4 is an early regulator of IL-6, IL-1β, and NF-κB activators' expression in pristane-induced arthritis.Gene therapy of the rheumatic diseases: 1998 to 2008.High avidity autoreactive T cells with a low signalling capacity through the T-cell receptor: central to rheumatoid arthritis pathogenesis?
P2860
Q24684755-88C7C433-ECB1-40C3-ACA5-425C766E6B8DQ24796801-534FB0C6-BD21-492B-8EB6-CA97C37FE224Q24805487-A6E0A2EC-BCDD-4A56-988E-C2482D735F1FQ24812982-50ABA4A1-F5D3-49D4-A10A-55CF08A8EE8EQ28366784-690BE5C6-DA7E-45C4-81EF-6FBDBB96C54FQ29617726-00376BFC-053F-457D-834A-39DA1D9B2113Q32045053-E2531990-DA5C-4E51-8272-9E6223083ACBQ34078075-A748D4E1-BE0B-4417-897D-7D1AE84669F9Q34084499-83115BEE-2661-489D-B2C2-67B9279C40D2Q34283578-13E828DE-53EC-48F7-B63B-1C1B9A9D8F62Q34293579-8CE82B48-0E37-4716-B90A-AA53938903DCQ34389834-38617FD0-0F90-464B-9619-11F92A362F6FQ34510718-428719AD-C507-4D61-8220-9F817C21C9A3Q34773767-0640A3D5-1C23-4EF1-95B3-94CE7A2485BEQ34895962-1A6CBC53-4104-4DD7-99EE-61E8D2FFA24EQ34962973-447DC5B7-55A1-4A14-9A53-805F9AAC468CQ35048399-930CDB8D-42B6-490C-A2B4-CC83240DCD7AQ35074047-E46698A9-5969-44EE-A3DD-1640968189DEQ35084427-7CB17DB5-0EEF-4A0C-955A-C500506D3255Q35120883-7CCAE896-4819-4001-B6E7-55A05030DE77Q35122155-23F208DA-C8F7-4F9B-9857-A7E8EDA08366Q35122176-98510D08-EA0C-40DD-AE84-61166A364C2BQ35151031-AE2D12D4-4E27-4E65-B880-A58D71F0CA1EQ35164793-7250686B-7E16-49EF-8DE5-0594BB5E504CQ35287485-DF0E5072-552F-475D-92D1-36B30C0234A5Q35605522-5C9E8D5A-4CF9-4E9A-896B-9AFA35D4B3B7Q35627680-67E99D0F-753A-41D6-B0A9-B8249C2057FBQ35696375-15876D4E-6815-41DA-9CB0-318C7ED1DADDQ35761406-B14AB76A-85E2-45AE-8896-E12E3AB45803Q35800463-BCA305E8-A8F4-4E1A-B158-39D6039EEFF8Q35882794-1E187BB8-098A-45ED-A801-A7D19C0EAC3AQ36287536-102C21C3-1444-4D5E-A9B6-7BC893ECF490Q36316769-DB031328-DA14-43D4-867F-D652C823010DQ36392394-125DE823-B2A6-40AA-908D-1D5C72C37610Q36573247-3D35D93D-50D8-4E16-A216-817821623E24Q36709522-73E6E5E3-0C81-4793-8AB5-64692EE65CA4Q36872163-6E000306-A5C3-4B64-ACF3-95BA4261723FQ37054708-BBFE21E4-B056-41A7-B235-46D9F597D3C8Q37207021-1B6072A6-9736-442F-A648-FE44AA718E20Q37246396-39DE5E42-AF40-46B1-AC7B-9F84AAFBE594
P2860
Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Suppressed severity of collage ...... nucleotides as a gene therapy.
@en
Suppressed severity of collage ...... nucleotides as a gene therapy.
@nl
type
label
Suppressed severity of collage ...... nucleotides as a gene therapy.
@en
Suppressed severity of collage ...... nucleotides as a gene therapy.
@nl
prefLabel
Suppressed severity of collage ...... nucleotides as a gene therapy.
@en
Suppressed severity of collage ...... nucleotides as a gene therapy.
@nl
P2093
P2860
P1476
Suppressed severity of collage ...... nucleotides as a gene therapy.
@en
P2093
Morishita R
Takeuchi E
P2860
P304
P356
10.1002/1529-0131(199912)42:12<2532::AID-ANR5>3.0.CO;2-2
P577
1999-12-01T00:00:00Z